Company Filing History:
Years Active: 2007-2010
Title: Stig S Frøland: Innovator in Immunotherapy
Introduction
Stig S Frøland is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of immunotherapy, particularly in the treatment and prevention of diseases such as AIDS. His innovative approaches have led to the development of valuable pharmaceutical methods.
Latest Patents
Frøland holds two patents that focus on groundbreaking methods for treating immunodeficiency disorders. His latest patents include a method of treating or preventing AIDS using COX-2 inhibitors. This invention provides a method wherein patients are administered a COX-2 inhibitor or its derivatives, such as diisopropylfluorophosphate, L-745337, rofecoxib, NS 398, SC 58125, etodolac, meloxicam, celecoxib, or nimesulide. Additionally, he has developed pharmaceutical compositions that are useful for treating immunosuppressive diseases, which contain compounds capable of inhibiting cAMP-dependent protein kinase A (PKA).
Career Highlights
Frøland is associated with Lauras AS, where he continues to advance his research and innovations. His work has been instrumental in the development of new therapeutic strategies that address critical health challenges.
Collaborations
Some of his notable coworkers include Kjetil Taskén and Einar Martin Aandahl. Their collaborative efforts have contributed to the success of various projects within the company.
Conclusion
Stig S Frøland's contributions to immunotherapy and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments that can significantly impact public health.